Inside Washington: Costs and Controls Challenge Manufacturers

February 15, 2002
Jill Wechsler
Jill Wechsler

Jill Wechsler is BioPharm International's Washington Editor,

BioPharm International, BioPharm International-02-01-2002, Volume 15, Issue 2
Page Number: 52-56

By Jill Wechsler, pp. 52-56. More curbs on reimbursement for expensive, cutting-edge therapies may shape R&D programs and industry growth